4',6-dihydroxyflavone has been researched along with lavendustin a in 1 studies
| Studies (4',6-dihydroxyflavone) | Trials (4',6-dihydroxyflavone) | Recent Studies (post-2010) (4',6-dihydroxyflavone) | Studies (lavendustin a) | Trials (lavendustin a) | Recent Studies (post-2010) (lavendustin a) |
|---|---|---|---|---|---|
| 10 | 0 | 3 | 174 | 0 | 5 |
| Protein | Taxonomy | 4',6-dihydroxyflavone (IC50) | lavendustin a (IC50) |
|---|---|---|---|
| Estrogen receptor beta | Mus musculus (house mouse) | 8 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 4.1 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 8 | |
| Estrogen receptor | Mus musculus (house mouse) | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
1 review(s) available for 4',6-dihydroxyflavone and lavendustin a
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |